The board-certified and fellowship-trained specialists at Norton Children’s provide innovative treatments and comprehensive care for young patients with bleeding, clotting and other benign (noncancer) hematology conditions.

Norton Children’s is home to the only pediatric hematology program and largest pediatric coagulation (clotting) center in Kentucky.

Norton Children’s Hospital is the leader in Kentucky and the only location in Louisville and Southern Indiana providing automated red cell exchange for children with sickle cell disease. It also provides care for adults, creating a solution for patients and families who seek lifelong care.

Early diagnosis is the key for children experiencing bleeding, clotting and other noncancer blood disorders.

The Norton Children’s hematology team uses sophisticated tests to track down blood disorders. Ashok B. Raj, M.D. leads the team as skilled investigators unravel medical mysteries and diagnose blood disorders from blood clots to sickle cell.

Collaborating with University of Louisville Physicians for your care

Norton Children’s works with providers from UofL Physicians to provide the best possible care for your child. These doctors are professors and active researchers helping to advance medical care in the 21st century with clinical research and education. Norton Children’s Hospital is the primary pediatric teaching hospital for the University of Louisville School of Medicine.

Our team includes board-certified pediatric hematologists, certified nurse practitioners, hematology nurse-specialists, social workers and others who care for children and teens.

The Norton Children’s difference

As home to the state’s leading pediatric hematology program, Norton Children’s offers sophisticated care for your child close to home.

Our pediatric coagulation center is the largest in the state, and our apheresis and photopheresis program treats a range of hematology issues.

Norton Children’s is home to the region’s only blood and marrow transplant program dedicated to treating children. Stem cell transplants are used to treat a variety of blood disorders.

In addition, Norton Children’s offers access to clinical trials that could offer novel treatments for your child’s condition.

Hematology treatment of blood disorders

We provide evaluation and treatment for a wide range of hematologic (blood) conditions, including sickle cell disease, hemostasis and thrombosis, hemophilia, immune thrombocytopenia (ITP), Von Willebrand disease and other platelet function disorders and rare anemia.

We customize treatment options for noncancerous blood conditions for each child and condition. Treatment plans may include adding or removing blood components (such as platelets or plasma), growth factor drugs and immunosuppressive drugs.

Norton Children’s Cancer Institute, affiliated with the University of Louisville, features the region’s only pediatric apheresis and photopheresis program. Apheresis can be used in treatment protocols for many blood disorders.

  • Apheresis (red cell depletion and exchange).

    We use this treatment for patients with a hematologic diagnosis, such as sickle cell anemia. Damaged red cells are removed and replaced with healthy red blood cells.

  • Plasmapheresis

    With this technique, we replace a patient’s blood plasma with plasma from a healthy donor. We use it to treat conditions such as thrombotic thrombocytopenic purpura (TTP) or organ rejection after a transplant.

Children with other blood diseases, such as hemophilia, congenital anemia, or aplastic anemia, might need regular administration of clotting factors or transfusion of blood cells, which can be done at our dedicated pediatric infusion center.

  • Factor replacement – This treatment can sometimes be administered in the clinic or at home and involves replacing missing clotting protein (factor concentrates). There are several factor concentrates on the market. They fall into two categories:
    • Plasma-derived

      Factor made using human plasma donations. They are then purified.

    • Recombinant

      Factor made using human genes placed into other cells that make human proteins FVIII or FIX. They are then purified.

  • Transfusion

    A more traditional approach that supplies the patient donor blood parts plasma, platelets or blood.

Hematology – 7725

Contact Us

Care close to Home

(502) 629-7725

Safety City: Field trip destination celebrates 25 years

If you were a second-grader in Jefferson County after 1993, chances are you took a field trip to Safety City. For 25 years, nearly 150,000 second-grade students from private, public, parochial and home school programs […]

Read Full Story

Sleep deprivation with a newborn? Restoring sleep habits may take year

Most parents realize they’re in for some sleep deprivation when having a newborn at home, but now researchers have determined it takes much longer for sleeping habits to return to normal. A recent studyfound sleep […]

Read Full Story

Leukemia in children: What it is, signs and symptoms

Leukemia is the most common cancer in children and teens, accounting for almost 1 out of 3 cancers. Most childhood leukemias are acute lymphocytic leukemia (ALL). Most of the remaining cases of leukemia in children […]

Read Full Story

Collaborative heart care helps Indiana boy’s Ebstein anomaly

Audrey Sims’ first clue that her twins’ birth would be complicated came at 14 weeks of pregnancy, when a routine ultrasound found that one of her sons, Aiden, had a blocked lymph node, which can […]

Read Full Story

What is congenital diaphragmatic hernia?

Diaphragmatic hernia is a hole in the diaphragm caused by a birth defect. The diaphragm is the large muscle that separates the chest from the abdomen. In a diaphragmatic hernia, organs such as intestines, spleen, […]

Read Full Story

Search our entire site.